Blog Sitemap
- Posts from 2025
-
Posts from 2022
- Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309
- Clean Cooling Comes of Age
- Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes
- Phononic, Sortimo turn Ford E-Transit into temp-controlled van for grocery delivery
- Adding AI to knowledge management is a $4.5M game-changer (VB On-Demand)
- Pryon’s Full-Stack AI Platform Delivers Industry-Leading Accuracy, Wins Top KMWorld AI50 Award
- Semiconductor firm Phononic taps former Fitbit exec as chief product officer
- Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion
- Arrivo BioVentures Closes Enrollment in Large Phase 2 Clinical Trial for Major Depressive Disorder
-
Posts from 2021
- We Upgraded our WordPress Website!
- Gauss Partners with State of California on New COVID-19 Antibody Study
- BioStable Science & Engineering Announces CE Mark Approval…
- Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes
- RFID tech helps Reading Hospital boost volume of COVID-19 vaccinations
- symplr Closes Its Acquisition Of Phynd
- Ro and Gauss Partner to Offer Rapid, At-Home COVID-19 Testing Nationwide
-
Posts from 2020
- Pediatric testing platform is producing accolades for Durham startup Baebies
- Olympus to acquire Veran Medical Technologies for $340m
- QuVa Pharma Expands Its Partnership With Kit Check™ to Help Hospitals Improve Medication Management and Automation Through RFID Tagging
- With new cash, Durham biopharma startup Emergo targets a big enemy: Flu
- REX Health Ventures co-leads $4.5M financing for Raleigh startup focusing on acute kidney injury treatment
- Austin biotech firm Biostable raises $4.2 million
- BioStable Science & Engineering Announces Initial Closing of Series C Equity Round
- Posts from 2019
-
Posts from 2018
- UNC Health Alliance and Phynd featured in Becker’s Hospital Review Article
- Veran Medical Receives $20M Investment from BTG
- Baebies and CureDuchenne Partner to Accelerate Newborn Screening for Duchenne Muscular Dystrophy
- KitCheck Bluesight officially launches
- Phynd releases information management platform 3.2
- Rex Health Ventures leads Emergo Therapeutics’ financing round
- Rex Health Ventures hosts Strategic Venture Summit
- UNC Health to partner with Apple Health’s Health Records feature
- Novartis partners with TARGET PharmaSolutions
- Quva Pharma to partner with Kit Check
-
Posts from 2017
- New study highlights increased accuracy when utilizing Veran Medical’s Thoracic Navigation Technology
- Boehringer Ingelheim partners with TARGET PharmaSolutions
- Kit Check has launched Bluesight for Controlled Substances
- Intercept extends strategic partnership with TARGET PharmaSolutions
- Phononic’s CEO selected as one of the 100 Most Intriguing Entrepreneurs of 2017 by Goldman Sachs
- Bristol-Myers Squibb extends strategic partnership with TARGET Pharma
- Phononic’s Solid State Fridge gains EPA award
- Baebies partners with Trivitron’s Labsystems Diagnostics
- UNC Healthcare utilizes Phononic to maintain medication temperatures
- TARGET PharmaSolutions enroll first patient in IBD Community
- Baebies SEEKER receives CE Mark
- Phononic’s solid-state fridge earns EPA award
- TARGET and Allergan partner on ongoing NASH study
- Veran launches new thoracic navigation software
- Durham’s Baebies Inc. gets FDA nod
- Phononic’s cooling technology, hot with investors, raises $40M
-
Posts from 2016
- Drug Developer Arrivo BioVentures Launches with $49M
- Veran Medical launches new lung navigation software, hardware and lung access tools
- Kit Check Automates 10 millionth Item Check on 850,000 Medications Tagged with RFID
- Bluewater Health signs on Awarepoint software
- FDA Advisors Back Approval of Baebies’ SEEKER Analyzer for Newborns
- TARGET PharmaSolutions novel clinical data model helps drug industry